Deutsche Bank’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3M Buy
1,093,291
+21,088
+2% +$66.8K ﹤0.01% 1561
2025
Q4
$3.97M Buy
1,072,203
+953,783
+805% +$3.08M ﹤0.01% 1418
2025
Q3
$314K Buy
118,420
+21,163
+22% +$40.9K ﹤0.01% 2820
2025
Q2
$95.3K Sell
97,257
-28,527
-23% -$28.6K ﹤0.01% 3277
2025
Q1
$181K Sell
125,784
-40,436
-24% -$74.5K ﹤0.01% 2997
2024
Q4
$366K Sell
166,220
-1,393,852
-89% -$3.25M ﹤0.01% 2787
2024
Q3
$2.57M Buy
1,560,072
+27,949
+2% +$56.4K ﹤0.01% 1610
2024
Q2
$3.4M Buy
+1,532,123
New +$3.6M ﹤0.01% 1384
2023
Q2
Sell
-48,413
Closed -$77K 3844
2023
Q1
$77K Buy
48,413
+15,668
+48% +$80.9K ﹤0.01% 3426
2022
Q4
$204K Buy
32,745
+3,927
+14% +$28.1K ﹤0.01% 2968
2022
Q3
$193K Sell
28,818
-4,212
-13% -$28.9K ﹤0.01% 2967
2022
Q2
$210K Buy
33,030
+2,605
+9% +$14.8K ﹤0.01% 3129
2022
Q1
$142K Buy
30,425
+13,284
+77% +$57K ﹤0.01% 3439
2021
Q4
$86K Sell
17,141
-1,889
-10% -$15.1K ﹤0.01% 3765
2021
Q3
$229K Sell
19,030
-985
-5% -$14.3K ﹤0.01% 3493
2021
Q2
$424K Sell
20,015
-874
-4% -$21K ﹤0.01% 3328
2021
Q1
$586K Sell
20,889
-1,588
-7% -$46.9K ﹤0.01% 3004
2020
Q4
$584K Buy
22,477
+6,382
+40% +$191K ﹤0.01% 2800
2020
Q3
$598K Buy
16,095
+2,279
+16% +$90.3K ﹤0.01% 2532
2020
Q2
$708K Sell
13,816
-165,119
-92% -$6.91M ﹤0.01% 2431
2020
Q1
$5.64M Sell
178,935
-17,541
-9% -$926K 0.01% 1188
2019
Q4
$11.7M Sell
196,476
-29,732
-13% -$1.34M 0.01% 1014
2019
Q3
$8.29M Sell
226,208
-148,416
-40% -$5.88M 0.01% 1164
2019
Q2
$17.4M Buy
374,624
+200,729
+115% +$9.43M 0.01% 1031
2019
Q1
$6.98M Buy
173,895
+161,930
+1,353% +$7.26M ﹤0.01% 1614
2018
Q4
$550K Sell
11,965
-129,405
-92% -$6.23M ﹤0.01% 3264
2018
Q3
$6.27M Buy
141,370
+17,062
+14% +$783K ﹤0.01% 2008
2018
Q2
$4.87M Sell
124,308
-40,132
-24% -$2.03M ﹤0.01% 2318
2018
Q1
$11.9M Sell
164,440
-11,347
-6% -$833K 0.01% 1478
2017
Q4
$11.6M Buy
175,787
+57,800
+49% +$3.11M 0.01% 1387
2017
Q3
$5.91M Sell
117,987
-49,885
-30% -$2.41M ﹤0.01% 1808
2017
Q2
$7.77M Sell
167,872
-138,288
-45% -$5.09M 0.01% 1593
2017
Q1
$10.8M Buy
306,160
+185,100
+153% +$4.24M 0.01% 1208
2016
Q4
$1.51M Sell
121,060
-148,449
-55% -$1.77M ﹤0.01% 2428
2016
Q3
$3.73M Buy
269,509
+46,642
+21% +$529K ﹤0.01% 1937
2016
Q2
$2.2M Sell
222,867
-215,592
-49% -$3.57M ﹤0.01% 2338
2016
Q1
$7.41M Sell
438,459
-31,836
-7% -$512K 0.01% 1466
2015
Q4
$10.5M Sell
470,295
-17,723
-4% -$447K 0.01% 1292
2015
Q3
$11.5M Buy
488,018
+324,084
+198% +$20.3M 0.01% 1206
2015
Q2
$13.4M Sell
163,934
-6,510
-4% -$637K 0.01% 1160
2015
Q1
$15.8M Buy
170,444
+27,761
+19% +$1.79M 0.01% 1063
2014
Q4
$5.77M Buy
142,683
+30,036
+27% +$919K ﹤0.01% 1839
2014
Q3
$2.75M Buy
112,647
+195
+0.2% +$3.1K ﹤0.01% 2276
2014
Q2
$1.78M Buy
112,452
+109,753
+4,066% +$1.59M ﹤0.01% 2516
2014
Q1
$40K Sell
2,699
-30,684
-92% -$476K ﹤0.01% 4633
2013
Q4
$458K Sell
33,383
-71,394
-68% -$1.04M ﹤0.01% 3183
2013
Q3
$1.97M Buy
+104,777
New +$1.76M ﹤0.01% 2502

Other funds holding ESPR